簡介

本頁面提供了有關 Adam Dubow 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Adam Dubow已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
US:DAWN / Day One Biopharmaceuticals, Inc. Gen Counsel & Secretary 0
US:BMY / Bristol-Myers Squibb Company SVP,ChiefCompliance&EthicsOff. 13,777
如何解讀這些圖表

以下圖表顯示了在Adam Dubow進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

歷史內部人交易

該表格顯示了由 Adam Dubow 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-04-23 2026-04-23 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
D - Sale to Issuer -72,694 0 -100.00
2026-02-18 2026-02-17 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -6,395 72,694 -8.09 11.60 -74,188 843,316
2026-02-18 2026-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 4,375 79,089 5.86
2026-02-18 2026-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 74,714 5.19
2026-02-18 2026-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,688 71,027 5.48
2026-02-18 2026-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 67,339 2.67
2026-02-18 2026-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,963 65,589 4.73
2025-11-18 2025-11-17 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -4,319 62,626 -6.45 8.91 -38,503 558,292
2025-11-18 2025-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 66,945 5.83
2025-11-18 2025-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 66,945 5.83
2025-11-18 2025-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 59,571 3.03
2025-11-18 2025-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,963 57,821 5.40
2025-08-19 2025-08-18 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -4,365 54,858 -7.37 6.77 -29,538 371,230
2025-08-19 2025-08-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 59,223 6.64
2025-08-19 2025-08-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 59,223 6.64
2025-08-19 2025-08-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 51,849 3.49
2025-08-19 2025-08-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,963 50,099 6.29
2025-05-19 2025-05-16 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -4,552 47,136 -8.81 6.26 -28,486 294,972
2025-05-19 2025-05-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 51,688 7.68
2025-05-19 2025-05-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 51,688 7.68
2025-05-19 2025-05-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 44,314 4.11
2025-05-19 2025-05-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,962 42,564 7.48
2025-02-21 2025-02-18 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -4,646 39,602 -10.50 11.96 -55,580 473,759
2025-02-21 2025-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 44,248 9.09
2025-02-21 2025-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 44,248 9.09
2025-02-21 2025-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 36,874 4.98
2025-02-21 2025-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,962 35,124 9.21
2024-11-19 2024-11-18 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -3,165 32,162 -8.96 13.21 -41,810 424,866
2024-11-19 2024-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 35,327 11.65
2024-11-19 2024-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 31,640 5.85
2024-11-19 2024-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,962 29,890 11.00
2024-08-19 2024-08-16 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -3,202 26,928 -10.63 14.00 -44,825 376,968
2024-08-19 2024-08-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 30,130 13.94
2024-08-19 2024-08-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 26,443 7.09
2024-08-19 2024-08-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,962 24,693 13.63
2024-05-17 2024-05-16 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -3,253 21,731 -13.02 16.08 -52,304 349,406
2024-05-17 2024-05-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 24,984 17.31
2024-05-17 2024-05-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 21,297 8.95
2024-05-17 2024-05-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,962 19,547 17.86
2024-02-20 2024-02-16 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -3,242 16,585 -16.35 15.25 -49,434 252,890
2024-02-20 2024-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 3,687 19,827 22.84
2024-02-20 2024-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 16,140 12.16
2024-02-20 2024-02-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 2,962 14,390 25.92
2023-11-17 2023-11-16 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
S - Sale -5,313 11,428 -31.74 11.69 -62,109 133,593
2023-11-17 2023-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 1,750 16,741 11.67
2023-11-17 2023-11-15 4 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
M - Exercise 11,850 14,991 377.27
2023-11-16 3 DAWN Day One Biopharmaceuticals, Inc.
Common Stock
3,141
2021-08-03 2021-07-30 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -2,466 13,777 -15.18 67.90 -167,441 935,469
2021-05-07 2021-05-05 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -3,119 16,243 -16.11 64.21 -200,271 1,042,973
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 5,972 5,972
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -2,495 0 -100.00
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 3,981 3,981
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -980 2,943 -24.98
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -1,062 2,124 -33.33
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -415 418 -49.82
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -452 0 -100.00
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -935 19,362 -4.61 60.93 -56,970 1,179,736
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 486 20,297 2.45
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 2,495 19,811 14.41
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -313 17,316 -1.78 60.93 -19,071 1,055,073
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 18 17,629 0.10
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 980 17,611 5.89
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -391 16,631 -2.30 60.93 -23,824 1,013,336
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 184 17,022 1.09
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 1,062 16,838 6.73
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -119 15,776 -0.75 60.93 -7,251 961,241
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -36 15,895 -0.23
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 415 15,931 2.67
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -152 15,516 -0.97 60.93 -9,261 945,399
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 30 15,668 0.19
2021-03-12 2021-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 452 15,638 2.98
2020-11-25 2020-11-24 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -900 15,186 -5.59 63.39 -57,051 962,650
2020-05-26 2020-05-22 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -3,200 16,086 -16.59 61.01 -195,232 981,416
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 5,885 5,885
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -2,707 0 -100.00
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 3,923 3,923
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -1,062 3,186 -25.00
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -415 833 -33.25
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -451 452 -49.94
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -372 0 -100.00
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -1,077 19,286 -5.29 57.93 -62,391 1,117,247
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 272 20,363 1.35
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 2,707 20,091 15.57
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -470 17,384 -2.63 57.93 -27,227 1,007,064
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 238 17,854 1.35
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 1,062 17,616 6.42
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -143 16,554 -0.86 57.93 -8,284 958,982
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -20 16,697 -0.12
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 415 16,717 2.55
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -182 16,302 -1.10 57.93 -10,543 944,384
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other 51 16,484 0.31
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 451 16,433 2.82
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -133 15,982 -0.83 57.93 -7,705 925,846
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -6 16,115 -0.04
2020-03-12 2020-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 372 16,121 2.36
2019-12-09 2019-12-05 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
S - Sale -1,740 15,749 -9.95 58.81 -102,329 926,208
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
A - Award 6,372 6,372
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Performance Shares
M - Exercise -2,196 0 -100.00
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
A - Award 4,248 4,248
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -415 1,248 -24.95
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -451 903 -33.31
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -369 372 -49.80
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Market Share Units
M - Exercise -304 0 -100.00
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -751 17,489 -4.12 51.39 -38,594 898,768
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 2,196 18,240 13.69
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -109 16,044 -0.67 51.39 -5,602 824,509
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -98 16,153 -0.60
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 415 16,251 2.62
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -138 15,836 -0.86 51.39 -7,092 813,820
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -49 15,974 -0.31
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 451 16,023 2.90
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -100 15,572 -0.64 51.39 -5,139 800,253
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -78 15,672 -0.50
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 369 15,750 2.40
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -84 15,381 -0.54 51.39 -4,317 790,437
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
J - Other -61 15,465 -0.39
2019-03-13 2019-03-10 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 304 15,526 2.00
2018-09-05 2018-09-03 4 BMY BRISTOL MYERS SQUIBB CO
Restricted Stock Units
M - Exercise -797 0 -100.00
2018-09-05 2018-09-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
F - Taxes -273 15,222 -1.76 60.55 -16,530 921,701
2018-09-05 2018-09-03 4 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
M - Exercise 797 15,495 5.42
2018-06-22 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
30,283
2018-06-22 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
16,472
2018-06-22 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
30,283
2018-06-22 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
16,472
2018-06-22 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
30,283
2018-06-22 3 BMY BRISTOL MYERS SQUIBB CO
Common Stock, $0.10 par value
16,472
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)